CJC-1295 + Ipamorelin vs IGF-1 LR3
Two secretagogues and analogs compounds, compared by what each molecule is: class, length, mass, origin and what it binds, side by side. Nothing here compares what either one does.
Specification
Side by side
| CJC-1295 + Ipamorelin | IGF-1 LR3 | |
|---|---|---|
| Class | Two-component research blend | Recombinant IGF-1 analog |
| Residues | 83 | |
| Sizes | 10 mg | 1 mg |
Origin and target
Where each one comes from, and what it binds
CJC-1295 + Ipamorelin
Origin. A blend of a GHRH analog and a ghrelin receptor ligand supplied in one vial.
Target. Two constituents acting on distinct receptor families, GHRH and the growth hormone secretagogue receptor.
Full referenceIGF-1 LR3
Origin. A modified insulin-like growth factor 1 analog, extended at the N-terminus and substituted at position 3.
Target. The IGF-1 receptor family. The modifications reduce its affinity for IGF binding proteins.
Full referenceRead next
Each one on its own page
Handling
The same for both
Both ship as freeze-dried powder, both mix with bacteriostatic water the same way, and both are stored at minus 20 C out of the light until then. What differs is which breakdown route each sequence is prone to, and the stability guide shows how to read that from the amino acids.
More comparisons
Others in secretagogues and analogs
Documentation
Both tested, both certificates published
Whichever you order, the latest lab certificate is on its product page.